Axsome Therapeutics Inc (AXSM)
87.15
-1.69
(-1.90%)
USD |
NASDAQ |
Nov 04, 16:00
87.16
+0.01
(+0.01%)
After-Hours: 20:00
Axsome Therapeutics Net Income (Quarterly): -79.34M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -79.34M |
| March 31, 2024 | -68.36M |
| December 31, 2023 | -98.65M |
| September 30, 2023 | -62.20M |
| June 30, 2023 | -67.17M |
| March 31, 2023 | -11.22M |
| December 31, 2022 | -61.24M |
| September 30, 2022 | -44.82M |
| June 30, 2022 | -41.44M |
| March 31, 2022 | -39.63M |
| December 31, 2021 | -33.98M |
| September 30, 2021 | -34.88M |
| June 30, 2021 | -32.28M |
| March 31, 2021 | -29.26M |
| December 31, 2020 | -29.16M |
| September 30, 2020 | -22.92M |
| June 30, 2020 | -18.33M |
| March 31, 2020 | -32.48M |
| December 31, 2019 | -24.81M |
| September 30, 2019 | -19.14M |
| Date | Value |
|---|---|
| June 30, 2019 | -13.76M |
| March 31, 2019 | -10.64M |
| December 31, 2018 | -9.597M |
| September 30, 2018 | -8.282M |
| June 30, 2018 | -8.281M |
| March 31, 2018 | -4.806M |
| December 31, 2017 | -7.430M |
| September 30, 2017 | -6.434M |
| June 30, 2017 | -7.084M |
| March 31, 2017 | -7.995M |
| December 31, 2016 | -7.329M |
| September 30, 2016 | -7.195M |
| June 30, 2016 | -6.812M |
| March 31, 2016 | -5.866M |
| December 31, 2015 | -3.365M |
| September 30, 2015 | -4.576M |
| June 30, 2015 | -2.129M |
| March 31, 2015 | -2.140M |
| December 31, 2014 | -1.489M |
| September 30, 2014 | -0.2531M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-98.65M
Minimum
Dec 2023
-11.22M
Maximum
Mar 2023
-43.80M
Average
-34.88M
Median
Sep 2021
Net Income (Quarterly) Benchmarks
| Krystal Biotech Inc | 15.57M |
| Pfizer Inc | 4.465B |
| Sarepta Therapeutics Inc | 6.46M |
| Moderna Inc | -1.279B |
| NovaBay Pharmaceuticals Inc | -1.585M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 87.17M |
| Total Expenses (Quarterly) | 163.05M |
| EPS Diluted (Quarterly) | -1.67 |
| Enterprise Value | 4.047B |
| Gross Profit Margin (Quarterly) | 90.76% |
| Profit Margin (Quarterly) | -91.03% |
| Earnings Yield | -7.47% |
| Normalized Earnings Yield | -6.413 |